<DOC>
	<DOCNO>NCT02462941</DOCNO>
	<brief_summary>Heart transplant save life nearly 500 child heart failure per year . Columbia one large pediatric heart transplant center world , average 25 transplant per year , provide ongoing care nearly 250 child transplant heart . After transplant , child increase risk develop sudden onset abnormally fast heart rate . This research project study adenosine , medication routinely use slow fast heart rate non-transplanted child ( i.e . normal heart ) , effect transplant heart . Adenosine often use patient transplanted heart , base prior limited research adult patient , standard adult dose may longer medication effect , produce slow heart rate undesirable period time . However , current alternative adenosine treatment either inappropriate pediatric age range , increase risk unwanted side effect . This research project answer two question : adenosine safe give child heart transplant , effective treat fast heart rate ? All pediatric heart transplant patient undergo regular heart testing , know cardiac catheterization , one time per year . Three day test , participant ask stop regular medication , dipyridamole , slow breakdown adenosine body , may increase effect . ( Of note , patient dipyridamole also aspirin , give second line heart protection , stop . ) After regular cardiac catheterization , patient already intravenous ( IV ) access give medication . Also , set allows opportunity back-up pace catheter heart , ensure longer desired effect medication . Adenosine give per low-dose protocol either medication effect see maximum dose reach . There difference procedure recovery period time , patient resume regular home medication finish test . As Columbia one large pediatric heart transplant center world , study effect adenosine low dos benefit investigator population greatly , either find new recommend medication dose , provide evidence medication truly inadvisable investigator patient .</brief_summary>
	<brief_title>Analysis Adenosine Sinus Atrioventricular Nodal Conduction Pediatric Transplanted Heart</brief_title>
	<detailed_description>After cardiac catheterization , study protocol begin 12.5µg/kg adenosine ( one eighth recommend start clinical dose ) , double 25µg/kg , 50µg/kg , 100µg/kg finally 200µg/kg ( surpass total maximum dose 12mg ) . A pacing catheter place within right ventricle prior medication administration . Escalating dos stop ventricular pacing require due ventricular pause great 12 second atrioventricular block demonstrate ventricular pause le 12 second . If prolong pause require pace demonstration medication effect subsequent dose give . Progression next dose adenosine depend primary secondary study outcome . If adenosine dose produce clinically significant bradycardia ( &gt; 12 second ) , ventricular pacing use maintain cardiac output , dose consider unsafe use clinically test end patient . If adenosine dose produce atrioventricular block pause le 12 second ( thus require pacing ) , dose consider effective study terminate well . However , adenosine dose produce atrioventricular block require pacing intervention , dose consider safe ineffective study progress next high dose . Before dose progression , study pause additional 30 second ensure complete adenosine metabolism , half-life adenosine less 10 second exhibit cumulative effect . The subsequent dose administer ECG observe clinically significant bradycardia atrioventricular block . This repeat clinically significant bradycardia and/or atrioventricular block observe , final 200μg/kg ( surpass total maximum 12mg ) dose .</detailed_description>
	<mesh_term>Bradycardia</mesh_term>
	<mesh_term>Atrioventricular Block</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<criteria>Patients undergone heart transplantation receive routine care Morgan Stanley Children 's Hospital New York , Columbia University Medical Center Patients admit inpatient heart failure team Patients present first outpatient catheterization new transplant Abnormal hemodynamics concern acute rejection Patients present follow rejection ( last biopsy positive ) Ingested methylxanthinecontaining food day Patients take oral dipyridamole discontinue 3 day prior test Prior transplant history coronary artery vasculopathy allograft concern abnormal coronary vasculature angiography day catheterization Patients take carbamazepine ( may potentiate adenosine effect ) Patients known conduction disease ( first , second third degree atrioventricular block ) and/or preexist sinus node dysfunction ( base preexisting ECG , Holter inpatient telemetry ) Patients/guardians unable give consent English</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Heart transplant</keyword>
	<keyword>Adenosine</keyword>
	<keyword>Pediatrics</keyword>
</DOC>